U.S. Biotech Stock News

In recent months, Blackstone’s US$82.00 billion Blackstone Private Credit Fund (BCRED) faced record investor redemption requests, prompting the firm to temporarily lift its quarterly withdrawal cap from 5% to 7% and commit US$400.00 million via a feeder fund so all requests could be met. This wave of outflows has sharpened the focus on liquidity and perceived risks in private credit, testing investor confidence in one of Blackstone’s fastest-growing business lines even as the firm emphasizes...

Calix (CALX) is back in focus after recent client announcements showed broadband providers ramping up their use of the Calix One platform, supported by multi year US federal programs such as BEAD. See our latest analysis for Calix. Calix shares currently trade at US$52.58, with a 30 day share price return of 17.71% contrasting with a year to date share price decline of 1.88%. The 1 year total shareholder return of 50.10% points to stronger longer term momentum alongside recent client wins...

TE Connectivity (TEL) shares extended a recent losing streak on Monday, even as the company reported a 42% rise in quarterly net income. This has raised questions about how geopolitical tensions and supply chain risks are affecting investor sentiment. See our latest analysis for TE Connectivity. The recent three day slide, including a 3.62% one day share price decline to US$204.31, contrasts with TE Connectivity’s 40% one year total shareholder return. This suggests short term pressure even...

Cadre Holdings stock: earnings growth puts the spotlight on upcoming results Cadre Holdings (CDRE) is back on investor radar after two years of strong annual revenue and earnings growth relative to sector peers. Attention is now turning to upcoming quarterly results and any signs of contract or integration pressure. See our latest analysis for Cadre Holdings. Cadre Holdings’ share price has climbed 12.25% over the past month and 9.22% year to date. Its 1 year total shareholder return of...

Zoetis (NYSE:ZTS) has agreed to acquire Neogen Corporation's animal genomics business. The transaction focuses on expanding Zoetis's Precision Animal Health capabilities, particularly in livestock genomics. The deal is intended to broaden Zoetis's global reach and tools for more individualized animal care. For Zoetis, a global animal health company with products spanning pet and livestock care, genomics fits directly into its push toward data driven and more targeted solutions. Precision...

Ultra Clean Holdings (UCTT) is back in focus after completing a US$525 million zero coupon senior unsecured notes offering, paired with a Board-approved share repurchase plan of up to US$40 million. See our latest analysis for Ultra Clean Holdings. Despite the recent 5.73% 1 day share price decline and 17.18% 7 day share price pullback, Ultra Clean’s 36.45% 30 day and 118.16% year to date share price returns, alongside a 150.74% 1 year total shareholder return, point to strong momentum. The...

TMC The Metals Company recently secured the first U.S. deep-seabed mining approval for a 65,000 km² area in the Clarion-Clipperton Zone, under an April 2025 executive order, aiming to advance its undersea nickel, cobalt, copper, and manganese project toward potential commercialization. This approval, combined with US$115.00 million in cash, no debt, and control of extensive nodule resources, strengthens TMC’s position as a prospective supplier to the battery metals supply chain despite...

If you are wondering whether Kohl's current share price reflects its underlying value, you are not alone. Many investors are asking the same question. The stock last closed at US$15.38, with returns of a 13.2% decline over 7 days, a 12.0% decline over 30 days, a 27.9% decline year to date, a 40.9% gain over 1 year, a 29.1% decline over 3 years, and a 63.9% decline over 5 years. Recent headlines around Kohl's have focused on the company as a traditional department store operator in a highly...

Recently, Healthcare Services Group reported strong fourth-quarter results with better-than-expected adjusted EBITDA, prompting RBC Capital to begin coverage and other analysts to reiterate their positive views on the company’s fundamentals. The latest analyst commentary highlights how improving skilled nursing facility economics and growing emphasis on clinical quality may support rising demand for Healthcare Services Group’s outsourced environmental and dietary services across U.S. care...

Burford Capital Limited has reported past fourth-quarter 2025 results showing revenue of US$33.41 million versus US$93.03 million a year earlier, swinging to a quarterly net loss of US$37.50 million and diluted loss per share of US$0.17, while its board also declared a final 2025 dividend of US$0.0625 per share, subject to shareholder approval. Despite weaker quarterly earnings, Burford highlighted a 39% rise in new definitive commitments and lifted its final 2025 dividend, underscoring...

How Surgery Partners' FY 2025 Numbers Set Up the Next Phase of Its Story Surgery Partners (SGRY) has closed out FY 2025 with fourth quarter revenue of US$885 million and a basic EPS loss of US$0.12, alongside a full year trailing revenue base of about US$3.3 billion and a trailing EPS loss of US$0.61. The company has seen quarterly revenue move from US$770.4 million in Q3 2024 to US$821.5 million in Q3 2025 and US$885 million in Q4 2025. Over the same period, quarterly EPS moved from a loss...

Winmark (WINA) has put fresh numbers on the table, reporting fourth quarter and full year 2025 results that show higher sales, revenue, net income, and earnings per share compared with the prior year. See our latest analysis for Winmark. Those results land after a strong run in the shares, with the latest share price at $480.67 and a 90 day share price return of 11.74%, while the 1 year total shareholder return of 55.13% and 5 year total shareholder return of about 3x suggest momentum has...

Graco (GGG) shares were caught up in a broader pullback after geopolitical tensions in the Middle East pushed crude oil prices higher, reviving inflation concerns and raising questions about interest rate timing for industrial names. See our latest analysis for Graco. Beyond today’s 2.5% decline in the share price, Graco’s recent news flow includes the launch of its Pulse Mobile fluid management system and an upcoming CFO transition. Its 30 day share price return of 5.86% and 90 day share...

American Express (NYSE:AXP) approved a 16% increase to its quarterly dividend. The company also announced plans to build a new global headquarters at 2 World Trade Center in Lower Manhattan. Both decisions highlight management’s capital allocation priorities and long term presence in New York City. American Express operates a global payments network and issues cards that target consumer, small business, and corporate spending. For investors, a higher dividend can change the mix of total...

Event context and recent share performance PDD Holdings (PDD) has been trading under pressure recently, with the stock down about 2% over the past day and roughly 6% over the past week as investors reassess sentiment around the business. See our latest analysis for PDD Holdings. Zooming out, the recent 1-day and 7-day share price declines fit into a weaker patch, with a 90-day share price return of 14.07% and a 1-year total shareholder return of 11.20%. This contrasts with a 7.52% total...

WEC Energy Group (WEC) is drawing fresh investor attention after adopting OneLayer Bridge to oversee cellular connected field devices across multiple carrier networks, a move tied to its broader digital infrastructure investments. See our latest analysis for WEC Energy Group. Against this operational backdrop, WEC Energy Group’s share price, last closing at $116.12, has posted a 4.92% 1 month share price return and 9.06% year to date share price return. Its 5 year total shareholder return of...

If you are wondering whether Webster Financial's current share price lines up with its underlying worth, or if the market is missing something, this article walks through the key numbers so you can judge the value for yourself. The stock last closed at US$68.77, with returns of 4.6% over 30 days, 7.8% year to date, 34.5% over 1 year, 51.8% over 3 years and 35.7% over 5 years, even after a 5.0% pullback over the past week. Recent news around Webster Financial has largely focused on the bank's...

A class action lawsuit has been filed alleging Apollo Global Management misled investors about its business relations with Jeffrey Epstein. The complaint claims senior leaders at Apollo communicated frequently with Epstein in the 2010s despite prior public denials. The suit names top executives and alleges material misstatements over several years regarding those interactions. For investors watching NYSE:APO, this lawsuit puts a spotlight on governance and disclosure practices at a time...

Acadia Healthcare Company (NasdaqGS:ACHC) recorded a substantial non cash goodwill impairment charge in Q4 2025. The impairment led to a significant net loss for both the quarter and the full year 2025. Operational growth continued through facility expansions and new joint ventures despite the non recurring charge. For investors watching Acadia Healthcare at a share price of $22.99, the goodwill impairment is a key development to factor into any assessment of the business. The stock has...

Wondering if Farmers National Banc at around US$13.13 is quietly offering value, or if the market has it about right? This article walks through what the numbers are really saying about the stock. The share price has been fairly steady recently, with a 0.1% slip over the last 7 days, a 1.2% gain over 30 days, a 1.1% decline year to date, and a 0.2% return over the past year. The 3 year and 5 year returns sit at 13.8% and 2.2% respectively. Alongside these returns, investors have been...

Intapp (INTA) has put agentic AI at the center of its story, launching the new Celeste platform and deepening collaborations with Anthropic’s Claude and Harvey to target tightly governed professional services workflows. See our latest analysis for Intapp. The recent product and partnership announcements have come alongside a sharp rebound in the share price, with an 11.5% 1 day share price return and 22.6% 7 day share price return. However, this follows a 42.1% 90 day share price decline and...

Transocean (NYSE:RIG) announced an agreement to acquire Valaris, aiming to combine two major offshore drilling fleets. The deal is expected to increase Transocean's contract backlog and reinforce its position in the offshore drilling market. Legal investigations and shareholder concerns have emerged around the transaction, adding uncertainty around timing and final terms. Transocean focuses on offshore contract drilling services for oil and gas companies, and Valaris operates in the same...

Erie Indemnity (NasdaqGS:ERIE) announced the planned retirement of CEO Tim NeCastro. The company has begun a formal search process to identify NeCastro’s successor. The transition will mark the end of a long tenure that included major company milestones. For investors watching Erie Indemnity at a share price of $272.16, this leadership change comes after mixed recent returns. The stock is up 5.9% over the past week, while showing a 3.8% decline over 30 days and a 2.0% decline year to date...

TG Therapeutics and Precision BioSciences reached a clinical milestone for azercabtagene zapreleucel (azer-cel) in a Phase 1 trial for progressive multiple sclerosis. The milestone is tied to early clinical progress in applying azer-cel, an allogeneic CAR T cell therapy, to autoimmune disease. This marks a step for TG Therapeutics in extending its pipeline beyond its core product into new neurological indications. TG Therapeutics, traded as NasdaqCM:TGTX, is drawing fresh attention as it...